| 5.24 Data as of May 24 |  +0.12 / +2.34%Today’s Change | 3.20 Today|||52-Week Range 7.08 | +13.17% Year-to-Date |
| Previous close | 5.12 |
| Today’s open | 5.04 |
| Day’s range | 5.04 - 5.29 |
| Volume | 57,202 |
| Average volume (3 months) | 81,647 |
| Market cap | $184.3M |
| Dividend yield | -- |
| Earnings growth (last year) | +55.61% |
| Earnings growth (this year) | +19.54% |
| Earnings growth (next 5 years) | +30.00% |
| Revenue growth (last year) | +11.81% |
| P/E ratio | NM |
| Price/Sales | 2.11 |
| Price/Book | 2.53 |
| Today’s change | Today’s % change | |
|---|---|---|
| ATECAlphatec Holdings In... | +0.01 | +0.52% |
| RTIXRTI Biologics Inc | -0.05 | -1.22% |
| DSCIDerma Sciences Inc | +0.20 | +1.45% |
| MDCIMedical Action Indus... | -0.43 | -5.58% |
| Next reporting date | July 30, 2013 |
| EPS forecast (this quarter) | -$0.17 |
| Annual revenue (last year) | $76.2M |
| Annual profit (last year) | -$30.1M |
| Net profit margin | -39.56% |
Sector Health Technology |
Industry Medical Specialties |
President, Chief Executive Officer & Director Mark J. Foley |
Senior Vice President- Operations Richard W. Poinsett, MBA |
Corporate headquarters Pleasanton, California |
.
